Cashu
Entero Therapeutics Progresses in Drug Development Amid Growing Market Interest
3 days ago
Stocks
Health Care
ento
Entero Therapeutics
ENTO
-0.00 (-0.54%)
0.4028
USD
At close at Jul 04, 20:40 UTC
Overview
Loading chart...
Key Stats
Market Cap
1.91M
Dividend Yield
0.00%
P/E Ratio
-0.08
EPS
-4.67
Revenue
-
Avg. Volume
38.21K
About
What does ENTO do?
First Wave Biopharma, headquartered in Boca Raton, Florida, develops nonsystemic therapies for gastrointestinal diseases and went public in October 2016. Its key programs include latiglutenase, capeserod, and adrulipase.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.